Clinical Trials on Multiple Myeloma and Plasma Cell Neoplasm in Germany
Total 2382 results
-
European Organisation for Research and Treatment...UnknownLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmFrance, Belgium, Netherlands, Germany, Italy
-
SanofiCompleted
-
iOMEDICO AGAmgenActive, not recruiting
-
University Hospital FreiburgMerck Sharp & Dohme LLC; Janssen-Cilag Ltd.Completed
-
Universitätsklinikum Hamburg-EppendorfRecruitingMultiple Myeloma | Multiple Myeloma in RelapseGermany
-
University of WuerzburgCompletedRefractory Multiple Myeloma | RelapseGermany
-
University Hospital TuebingenCompletedRelapsed or Refractory Multiple MyelomaGermany
-
Technische Universität DresdenGerman Cancer Research CenterRecruitingNeoplasms | Multiple Myeloma in Relapse | Multiple Myeloma, Refractory | Relapsed Diffuse Large B-cell Lymphoma (DLBCL) | Refractory Diffuse Large B-cell Lymphoma (DLBCL)Germany
-
Novartis PharmaceuticalsTerminatedMultiple Myeloma Stage IGermany
-
AmgenActive, not recruitingRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid LeukemiaUnited States, Australia, Japan, Germany, Canada
-
University Hopsital Schleswig Holstein Campus LübeckRecruitingNewly Diagnosed Multiple MyelomaGermany
-
SanofiActive, not recruitingPlasma Cell MyelomaItaly, Korea, Republic of, Norway, Canada, Spain, Germany, Greece, Lithuania, Sweden, Israel, Hungary, France, Japan, Australia, China, Denmark, Czechia, Turkey, United States, Brazil, Ireland, New Zealand, Poland, United Kingdom
-
University of CologneJanssen-Cilag G.m.b.HRecruiting
-
SanofiRecruitingPlasma Cell Myeloma RecurrentUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Czechia, France, Germany, Greece, Hungary, Italy, Japan, Norway, Poland, Spain, Sweden, Taiwan, Turkey, United Kingdom
-
iOMEDICO AGDeutsche Studiengruppe Multiples Myelom (DSMM)Recruiting
-
Heidelberg Pharma AGRecruitingMultiple Myeloma | Plasma Cell DisorderUnited States, Germany, Poland, Hungary
-
Oncopeptides ABTerminatedRelapsed Multiple Myeloma | Relapsed-Refractory Multiple MyelomaSerbia, Greece, Russian Federation, Czechia, Bulgaria, Georgia, Norway, Poland, Spain, Ukraine, Germany
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Recurrent Adult Acute Myeloid Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Non-Hodgkin Lymphoma | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Plasma Cell MyelomaUnited States, Germany, Italy
-
Janssen Research & Development, LLCApproved for marketingRelapsed or Refractory Multiple MyelomaBrazil, Germany, Italy, Netherlands, Romania, Switzerland, United Kingdom
-
GWT-TUD GmbHActive, not recruitingRefractory Multiple MyelomaGermany
-
SanofiRecruitingPlasma Cell MyelomaGermany, United States, Argentina, China, France, Hong Kong, Italy, Japan, Puerto Rico, Spain, Switzerland, United Arab Emirates, United Kingdom, Austria, Belgium, Netherlands, Taiwan
-
University Hospital Carl Gustav CarusCompleted
-
SanofiCompletedPlasma Cell MyelomaFrance, Spain, Greece, Korea, Republic of, United States, Australia, Belgium, Canada, Czechia, Denmark, Germany, Hungary, Italy, Japan, New Zealand, Norway, Poland, Portugal, Russian Federation, Slovakia, Sweden, Taiwan, Turkey, United...
-
Novartis PharmaceuticalsCompletedRelapsed and Refractory Multiple MyelomaItaly, Germany, Singapore, Australia, United States
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaGermany, Spain, Singapore, United States, Australia
-
University of Heidelberg Medical CenterGerman Cancer Research Center; University Hospital Heidelberg; Array BioPharma; Coordinating Centre for Clinical Trials HeidelbergActive, not recruitingRelapsed or Refractory Multiple Myeloma | Patients With BRAFV600 E or BRAFV600K MutationGermany
-
Anaveon AGTerminatedHematologic Diseases | Multiple Myeloma | Refractory Multiple Myeloma | Adult Disease | Relapsed CancerSpain, Germany, France, Denmark, Switzerland
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Polyphor Ltd.Completed
-
Novartis PharmaceuticalsActive, not recruitingMultiple Myeloma (MM)United States, Italy, Israel, Germany, Japan, Spain, Australia, Norway
-
Arbeitsgemeinschaft medikamentoese TumortherapieAmgen; Assign Data Management and Biostatistics GmbHActive, not recruitingMultiple MyelomaAustria, Germany, Israel
-
Janssen-Cilag Ltd.RecruitingRelapsed/Refractory Multiple Myeloma (RRMM)France, Denmark, Israel, Spain, Italy, Germany, Sweden
-
SanofiActive, not recruitingPlasma Cell MyelomaMexico, Sweden, Poland, France, Czechia, Greece, Taiwan, Lithuania, Portugal, Spain, Australia, Italy, New Zealand, Russian Federation, Turkey, Japan, United States, Belgium, China, Denmark, Germany
-
Molecular Partners AGCompletedMultiple Myeloma in RelapsePoland, Italy, Germany, Denmark, Czechia, Austria
-
iOMEDICO AGCompleted
-
University of LeipzigMundipharma Pte Ltd.; Celgene Corporation; AmgenUnknown
-
University Hospital, BonnUnknown
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Novartis PharmaceuticalsCompletedMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaItaly, Australia, Germany, Spain, France, Japan, United States
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...RecruitingRelapsed and/or Refractory Multiple MyelomaUnited States, France, Spain, Germany
-
Janssen Research & Development, LLCCompletedHigh-risk Smoldering Multiple MyelomaUnited States, United Kingdom, Belgium, Germany, France, Spain, Korea, Republic of, Australia, Israel, Greece, Sweden
-
Wuerzburg University HospitalClinAssess GmbH; Arbeitsgemeinschaft medikamentoese TumortherapieActive, not recruitingNewly Diagnosed Multiple MyelomaGermany, Austria
-
Hoffmann-La RocheCompletedMultiple Myeloma, NeoplasmsUnited States, China, France, Spain, United Kingdom, Germany
-
Patrys Ltd.Completed
-
Wuerzburg University HospitalCelgene Corporation; ClinAssess GmbHActive, not recruitingPreviously Untreated Symptomatic Multiple MyelomaGermany
-
Universitätsklinikum Hamburg-EppendorfClinical Trial Center North (CTC North GmbH & Co. KG); RiemserActive, not recruiting
-
Janssen Research & Development, LLCRecruitingRelapsed/ Refractory Multiple MyelomaUnited States, Germany, Spain, France
-
Prof. Dr. Andreas EngertThe Clinical Trials Centre CologneTerminated
-
European Myeloma NetworkCompletedMultiple Myeloma | Hematologic MalignanciesSpain, Sweden, Germany, Italy